Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155218813716
Abstract: Trastuzumab emtansine is an antibody–drug conjugate that is effective in human epidermal growth factor receptor-2 expressing advanced breast cancer. Trastuzumab emtansine is generally well tolerated and grade 3–4 toxicities are rare. Pulmonary complications were rarely…
read more here.
Keywords:
pneumonitis associated;
trastuzumab emtansine;
associated trastuzumab;
interstitial pneumonitis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.651553
Abstract: Background Immune checkpoint inhibitors (ICIs) have dramatically altered the treatment landscape for patients with melanoma. However, their use also generates unique immune-related adverse effects (irAEs). We performed a systematic review and network meta‐analysis to compare…
read more here.
Keywords:
risk;
pneumonitis associated;
grade;
risk pneumonitis ... See more keywords